← Open Payments lookup

GISELA CHIN: Open Payments

NPI 1760131486 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,847 in 98 payments from 19 companies in 2025. Trend: 2023 $18 · 2024 $209 · 2025 $1,847

Food & beverage: $1,763Education: $84
CompanyPaymentsAmount
ABBVIE INC.38$695
PFIZER INC.18$247
Janssen Biotech, Inc.11$244
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$88
Phathom Pharmaceuticals, Inc.3$76
GENZYME CORPORATION4$70
Lilly USA, LLC2$62
Celltrion USA Inc.3$53
Takeda Pharmaceuticals U.S.A., Inc.2$49
Gilead Sciences, Inc.2$49

Products named: TREMFYA, RINVOQ, SKYRIZI, VELSIPITY, CREON, LINZESS, DUPIXENT, VOQUEZNA.

Industry payments across NV — which companies pay providers there.